Search

Displaying results 7171 - 7180 of 7452 in total
  1. Drug

    NLX-P101

    go.drugbank.com/drugs/DB05924
    Experimental

    NLX-P101, gene therapy is developed by Neurologix to treat Parkinson’s disease. The gene is glutamic acid decarboxylase (GAD), whose product synthesizes the major inhibitory neurotransmitter in the brain, (gamma)-aminobutyric acid (GABA)...

  2. Drug

    Istaroxime

    go.drugbank.com/drugs/DB06157
    Investigational

  3. Drug

    Indibulin

    go.drugbank.com/drugs/DB06169
    Investigational

  4. Drug

    Paclitaxel trevatide

    go.drugbank.com/drugs/DB06171
    Investigational

    Three paclitaxel molecules linked by a cleavable succinyl ester linkage to a brain peptide vector, Angiopep-2, conjugate named ANG1005.

  5. Drug

    R112

    go.drugbank.com/drugs/DB06252
    Experimental

    R112 is an investigational compound developed to treat Allergic Rhinitis. It's mechanism of action is to inhibit SYK kinase.

  6. Drug

    MLN2704

    go.drugbank.com/drugs/DB06513
    Investigational

    A Phase 1/2 trial (NCT00070837) evaluated the safety, dosage, and pharmacokinetics of MLN2704 in patients with metastatic androgen-independent prostate cancer.

  7. Drug

    Lanimostim

    go.drugbank.com/drugs/DB06559
    Experimental

  8. Drug

    Vipadenant

    go.drugbank.com/drugs/DB06625
    Investigational

  9. Drug

    Zibotentan

    go.drugbank.com/drugs/DB06629
    Investigational

  10. Drug

    Aldoxorubicin

    go.drugbank.com/drugs/DB06013
    Investigational

    Aldoxorubicin, an antineoplastic agents, is an albumin-binding prodrug of doxorubicin.